Invesco’s Inhibrx INBX Stock Holding History

Invesco’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.6M	Sell	16,858 -6,498	-28%	-$651K	﹤0.01%	2683
2026 Q1	$1.57M	Sell	23,356 -89,040	-79%	-$6.6M	﹤0.01%	2660
2025 Q4	$8.88M	Buy	112,396 +94,822	+540%	+$6.46M	﹤0.01%	1922
2025 Q3	$592K	Buy	17,574 +4,082	+30%	+$100K	﹤0.01%	3165
2025 Q2	$193K	Buy	+13,492	New	+$174K	﹤0.01%	3518
2024 Q3	–	Sell	-21,386	Closed	-$303K	–	3812
2024 Q2	$303K	Buy	+21,386	New	+$334K	﹤0.01%	3496

Other funds holding INBX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SSA

Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco's INBX Position: Q2 2026 in Review

Invesco reduced its Inhibrx (INBX) stake by 28% in Q2 2026, selling an estimated $651K and leaving 16,858 shares worth $1.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Invesco first reported a position in INBX in Q2 2024 and has held it in 6 quarters since. The position peaked at $8.88M in Q4 2025. 163 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

Invesco held 16,858 shares of Inhibrx worth $1.6M as of Q2 2026.
Invesco sold 6,498 Inhibrx shares in Q2 2026, an estimated $651K.
Inhibrx made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #2683 holding.
Invesco first reported a position in Inhibrx in Q2 2024 and has held it in 6 quarters since.
Invesco's Inhibrx position peaked at $8.88M in Q4 2025.
163 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.